this work references cited by second hopReferences
- 1976The SCL-90 and the MMPI: A Step in the Validation of a New Self-Report Scale2,298 cited
- 2003The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)1,271 cited
- 1997SKID I. Strukturiertes Klinisches Interview für DSM-IV. Achse I: Psychische Störungen. Interviewheft und Beurteilungsheft. Eine deutschsprachige, erweiterte Bearb. d. amerikanischen Originalversion des SKID I768 cited
- 2010Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)682 cited
- 1998The Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans577 cited
- 2000The Symptom Check-List-90-R (SCL-90-R): A German validation study430 cited
- 1988Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites301 cited
- 2000Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) are Attenuated by the Serotonin Uptake Inhibitor Citalopram248 cited
- 2002Das Freiburger-Persönlichkeitsinventar (FPI)193 cited
- 2011The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (“Ecstasy”) in Humans152 cited
- 2006A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers149 cited
- 2007Pharmacological Interaction between 3,4-Methylenedioxymethamphetamine (Ecstasy) and Paroxetine: Pharmacological Effects and Pharmacokinetics113 cited
- 2006The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans
Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work